Patents by Inventor Jason Robles REYES

Jason Robles REYES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions
    Patent number: 12103958
    Abstract: The invention provides LFA3 polypeptide molecules, e.g., variant LFA3 fusion polypeptide molecules. The invention includes uses, and associated methods of using the LFA3 polypeptide molecules.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: October 1, 2024
    Assignees: Pfizer Inc., The Regents of the University of California
    Inventors: Natasha Kay Crellin, Lauren Kate Ely, Jason Robles Reyes, Chia Chi Ho, Jeffrey A. Bluestone, Eleonora Trotta, Qizhi Tang
  • LFA3 VARIANTS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20210032308
    Abstract: The invention provides LFA3 polypeptide molecules, e.g., variant LFA3 fusion polypeptide molecules. The invention includes uses, and associated methods of using the LFA3 polypeptide molecules.
    Type: Application
    Filed: September 28, 2020
    Publication date: February 4, 2021
    Inventors: Natasha Kay CRELLIN, Lauren Kate ELY, Jason Robles REYES, Chia Chi HO, Jeffrey A. BLUESTONE, Eleonora TROTTA, Qizhi TANG